Neogen (FRA:NG2) Cyclically Adjusted FCF per Share: €0.25 (As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:NG2 Neogen Corp FRA:NG2
69 GF Score
Price €8.56
GF Value €10.19
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Neogen Cyclically Adjusted FCF per Share?

Neogen FRA:NG2 +2.54% 69 Cyclically Adjusted FCF per Share is €0.25 as of Feb. 2026. GuruFocus rates FRA:NG2 with a GF Score™ of 69/100 and a GF Value™ of €10.19 (Modestly Undervalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Neogen's adjusted free cash flow per share for the three months ended in Feb. 2026 was €0.043. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €0.25 for the trailing ten years ended in Feb. 2026.

During the past 12 months, Neogen's average Cyclically Adjusted FCF Growth Rate was -6.50% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -11.30% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was -1.80% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 8.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Neogen was 44.20% per year. The lowest was -11.30% per year. And the median was 15.05% per year.

As of today (2026-07-17), Neogen's current stock price is €8.564. Neogen's Cyclically Adjusted FCF per Share for the quarter that ended in Feb. 2026 was €0.25. Neogen's Cyclically Adjusted Price-to-FCF of today is 34.26.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Neogen was 178.70. The lowest was 14.16. And the median was 102.59.


Neogen  (FRA:NG2) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Neogen's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=8.564/0.25
=34.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Neogen was 178.70. The lowest was 14.16. And the median was 102.59.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Neogen Cyclically Adjusted FCF per Share Related Terms


Neogen Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Neogen's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neogen Cyclically Adjusted FCF per Share Chart

Neogen Annual Data
Trend May16 May17 May18 May19 May20 May21 May22 May23 May24 May25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.30 0.40 0.36 0.34 0.28

Neogen Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.30 0.28 0.25 0.25 0.25

FRA:NG2 vs UFPT, ALMR, BFLY: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Neogen's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neogen Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Neogen's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Neogen's Cyclically Adjusted Price-to-FCF falls into.


FRA:NG2
69GF Score
Neogen Corp FRA:NG2
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Neogen Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Neogen's adjusted Free Cash Flow per Share data for the three months ended in Feb. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Feb. 2026 (Change)*Current CPI (Feb. 2026)
=0.043/326.7850*326.7850
=0.043

Current CPI (Feb. 2026) = 326.7850.

Neogen Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201605 0.037 240.229 0.050
201608 0.148 240.849 0.201
201611 0.059 241.353 0.080
201702 0.081 243.603 0.109
201705 0.119 244.733 0.159
201708 0.117 245.519 0.156
201711 0.022 246.669 0.029
201802 0.103 248.991 0.135
201805 0.144 251.588 0.187
201808 0.116 252.146 0.150
201811 0.098 252.038 0.127
201902 0.044 252.776 0.057
201905 0.154 256.092 0.197
201908 0.147 256.558 0.187
201911 0.089 257.208 0.113
202002 0.141 258.678 0.178
202005 0.155 256.394 0.198
202008 0.166 259.918 0.209
202011 0.123 260.229 0.154
202102 0.025 263.014 0.031
202105 0.111 269.195 0.135
202108 0.172 273.567 0.205
202111 0.113 277.948 0.133
202202 -0.001 283.716 -0.001
202205 0.069 292.296 0.077
202208 -0.248 296.171 -0.274
202211 -0.140 297.711 -0.154
202302 -0.139 300.840 -0.151
202305 0.278 304.127 0.299
202308 -0.032 307.026 -0.034
202311 -0.037 307.051 -0.039
202402 -0.267 310.326 -0.281
202405 0.011 314.069 0.011
202408 -0.236 314.796 -0.245
202411 0.100 315.493 0.104
202502 -0.059 319.082 -0.060
202505 0.001 321.465 0.001
202508 -0.052 323.976 -0.052
202511 0.031 324.122 0.031
202602 0.043 326.785 0.043

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €0.25 mean?
Neogen (FRA:NG2) has a Cyclically Adjusted FCF per Share of €0.25 as of Feb. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Neogen and its competitors.
Is Neogen's Cyclically Adjusted FCF per Share too high?
Neogen's current Cyclically Adjusted FCF per Share is €0.25. Overall, Neogen has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Neogen's Cyclically Adjusted FCF per Share compare to UFPT and ALMR?
Neogen's Cyclically Adjusted FCF per Share of €0.25 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Neogen and its competitors. Neogen's current Cyclically Adjusted FCF per Share is €0.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neogen stock overvalued right now?
Based on GuruFocus' analysis, Neogen (FRA:NG2) is currently considered Modestly Undervalued. The stock's GF Value™ is €10.19, compared to a current price of €8.56 — trading 16% below its estimated fair value. The current Cyclically Adjusted FCF per Share is €0.25. Neogen's overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Neogen (FRA:NG2), the current Cyclically Adjusted FCF per Share is €0.25 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Neogen (FRA:NG2) Overvalued in 2026?

Based on GuruFocus' analysis, Neogen stock appears to be undervalued. The current stock price of €8.56 is trading 16% below its estimated GF Value™ of €10.19. GuruFocus considers Neogen to be Modestly Undervalued.

Key valuation signals for FRA:NG2:

  • Cyclically Adjusted FCF per Share: €0.25
  • GF Value™: €10.19 vs. price of €8.56 (16% below fair value)
  • GF Score™: 69/100 with 6 warning signs

No single metric tells the full story. See the FRA:NG2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Neogen Business Description

Other Exchanges NEOG:USANG2:Germany
Address 620 Lesher Place, Lansing, MI, USA, 48912
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.
69GF Score

Get the complete analysis for FRA:NG2

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.56
Price
€10.19
GF Value